Susceptibility of clinical isolates of Candida glabrata to new triazoles

International Journal of Antimicrobial Agents

Volumn 21, Issue 4, 2003, Pages 360-361

  Swoboda Kopec, E ^a,b   Wroblewska, M ^a   Rokosz, A ^a   Krawczyk, E ^a   Luczak, M ^a,b   Sulik Tyszka, B ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Central Clinical Hospital in Warsaw   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; TRIAZOLE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CANDIDA GLABRATA; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS ISOLATION; HOSPITAL INFECTION; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; URINARY TRACT INFECTION;

EID: 0037382932     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(02)00385-0     Document Type: Letter

References (17)

1. Meis J.F., Verweij P.E. Current management of fungal infections. Drugs. 61:2001;S13-S25.
2. Hoffman H.L., Ernst E.J., Klepser M.E. Novel triazole antifungal agents. Expert. Opinion. Investigat. Drugs. 9:2000;593-605.
3. Vazquez J.A., Peng G., Sobel J.D., et al. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis. Clin. Infect. Dis. 33:2001;1069-1075.
4. Safdar A., van Rhee F., Henslee-Downey J.P., Singhal S., Mehta J. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. Bone Marrow Transplant. 28:2001;873-878.
5. Espinel-Ingroff A., Rodriguez-Tudela J.L., Martinez-Suarez J.V. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole - resistant and -susceptible isolates of Candida albicans. J. Clin. Microbiol. 33:1995;3154-3158.
6. Willinger B., Apfalter P., Hirschl A.M., Makristathis A., Rotter M., Seibold M. Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest. Diagn. Microbiol. Infect. Dis. 1:2000;11-15.
7. Swinne D., Raes-Wuytack C., Van Looveren K., Desmet P. Comparative evaluation of Fungitest Neo-Sensitabs. and. M27T- NCCLS. broth. microdilution. methods. for. antifungal. drug. susceptibility. testing. of. Candida. species. and. Cryptococcus. neoformans. Mycoese. 42:1999;231-237.
8. Wong-Beringera A., Hindler J., Brankovic L., Muehlbauer L., Steele-Moore L. Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients. Diagn. Microbiol. Infect. Dis. 39:2001;25-31.
9. Pfaller M.A., Jones R.N., Doern G.V., et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America 1997-1998. Antimicrob Agents Chemother. 44:2000;747-751.
10. Baddley J.W., Smith A.M., Moser S.A., Pappas P.G. Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a university hospital. Diagn. Microbiol. Infect. Dis. 39:2001;199-201.
11. Kauffman C.A., Vazquez J.A., Sobel J.D., et al. Prospective multicenter surveillance study of funguria in hospitalized patients. Clin. Infect. Dis. 30:2000;14-18.
12. Rocco T.R., Reinert S.E., Simms H.H. Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance. Arch. Surg. 135:2000;160-165.
13. Martin M.V. The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review. J. Antimicrob. Chemother. 44:1999;429-437.
14. Sanglard D., Ischer F., Bilk J. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob. Agents Chemother. 45:2001;1174-1183.
15. Glasmacher A., Hahn C., Molitor E., et al. G. Fungal surveillance cultures during antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia. Mycoses. 42:1999;395-402.
16. Koul A., Vitullo J., Reyes G., Ghannoum M. Effects of voriconazole on Candida glabrata in vitro. J. Antimicrob. Chemother. 44:1999;109-112.
17. Pfaller M.A., Jones R.N., Doern G.V., et al. International surveillance of blood stream infections due to #Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe). Diagn. Microbiol. Infect. 35:1999;19-25.